Want to join the conversation?
$BWA spent about 7.3% of sales on capital in 3Q15, which is above its long-term target of 5% to 6%. Capital spending is primarily from machinery and equipment. However, $BWA's growth over the next several years does require investments in new plants, plant expansions, which is driving elevated spending in the near term.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.